AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Share Issue/Capital Change Dec 11, 2025

7665_rns_2025-12-11_f9867f7a-0691-4e70-aa88-beb3b89da721.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2640L

Geiger Counter Ltd

11 December 2025

Geiger Counter Limited

(the "Company")

Net Asset Value

Geiger Counter Limited (LSE: GCL) announces that as at the close of business on 10 December 2025 its unaudited net asset value ("NAV") per ordinary share ("Share") was as follows:

Date of announcement 11 December 2025
Date of NAV 10 December 2025
NAV per share - undiluted 68.96 pence per share
NAV per share - fully diluted* 63.66 pence per share
No of voting shares in issue 104,836,041
Subscription Exercise Price 37.20 pence per share
Next Subscription Date 1 May 2026

*Notes relating to the NAV dilution

The dilution is in relation to the effect of the Company's embedded annual Subscription Right. Shareholders should note that the dilution refers to the NAV per share dilution, not to the dilution of Shareholders' holdings in the Company. All Shareholders have the right to take up their subscription rights on 1 May in each year and those who do take them up in full don't have their percentage holding in the Company diluted. For those investors who don't take up their subscription rights, the Company endeavours to place in the market the shares that they were entitled to subscribe for, and then return the net sale proceeds to those investors as a way to deliver to them as much as possible of the value of their subscription rights, therefore reducing the dilution effect of not subscribing.

About the annual Subscription Right

Shareholders have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on the Record Date, as outlined in the circular published on 31 March 2021. The exercise price is equal to the undiluted NAV per share on 30 April one year prior. The aim of the programme is to enable to Company to grow through share issuance and it is subject to shareholder review at the annual general meeting ("AGM") in 2026 and at every fifth subsequent AGM thereafter.

Enquiries

Manulife | CQS Investment Management

Craig Cleland +44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Daniel Balabanoff / Pauline Tribe (Sales +44 (0) 20 7720 0500)

Tunga Chigovanyika (Corporate Finance Director +44 (0) 20 7397 1915)

Summit Fund Services Jersey Limited

Christopher Foulds +44 (0) 1534 825 259

About Geiger Counter Limited

Geiger Counter Limited is a closed-ended investment company incorporated with limited liability in Jersey. The Company's investment objective is to provide attractive returns to Shareholders principally in form of capital growth, through investment in companies involved in the exploration, development and production or uranium to supply the nuclear power industry.

For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVBUBDDISBDGUB

Talk to a Data Expert

Have a question? We'll get back to you promptly.